The Cardiovascular Inflammation Test (CIT) by KBMO Diagnostics is a comprehensive blood analysis designed to evaluate and monitor multi-dimensional cardiometabolic risks. By analyzing critical markers across three primary categories—Lipids, Metabolics, and Inflammation—the CIT provides a detailed roadmap for preventing, treating, and reversing common lifestyle diseases such as type 2 diabetes, metabolic syndrome, and cardiovascular disease. The panel includes advanced indicators like Apolipoprotein B (apoB) and Lipoprotein(a), which offer more precise predictive value than standard cholesterol tests alone. Additionally, it tracks hs-CRP to identify systemic inflammation and HbA1c for long-term glucose management. This test is an essential tool for those seeking to unmask hidden health risks and implement targeted interventions to improve long-term quality of life. Recommended use: As directed by your healthcare professional based on your specific clinical history, risk factors, and diagnostic requirements. This information is provided as a medical and scientific educational resource for licensed health‑care practitioners and not intended for use by consumers for medical treatments of illness or disease. All recommendations regarding protocols, dosing, prescribing, and/or usage instructions should be tailored to the individual needs of the patient considering their medical history and provided by their treatment practitioner. Any information contained within should not be constructed as healthcare claims nor should it be used as a suggested guideline. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Related
Related
Related
Related